glp 1 agonist benefits The of GLP-1 Therapy: Beyond Weight Loss GLP-1 Agonists For Obesity In

Pract Diabetes Int

Patients should be very cautious

I have been long LLY and NVO because of GLP-1 drugs since early 2022, but as evidence continues to amass in favour of their utility for a large population its worth considering - what other implications does this have

Acta Endocrinol (Buchar)

The FDA does not verify supplement claims before products reach consumers, and manufacturers are not required to demonstrate efficacy through clinical trials, though they must report serious adverse events to the FDA

Beyond just its function as a satiety mediator, GLP-1 has been demonstrated to exhibit effects on memory and learning, specifically through its action on the hippocampus